270 related articles for article (PubMed ID: 25086486)
1. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during
Jamalludin Z; Jong WL; Malik RA; Rosenfeld AB; Ung NM
Phys Med; 2020 Jan; 69():52-60. PubMed ID: 31830631
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
Haughey A; Coalter G; Mugabe K
Australas Phys Eng Sci Med; 2011 Sep; 34(3):361-6. PubMed ID: 21710233
[TBL] [Abstract][Full Text] [Related]
5. In-vivo Comparison of Planned and Measured Rectal Doses during Cobalt-60 HDR CT-based Intracavitary Brachytherapy Applications of Cervical Cancer Using the PTW 9112 Semiconductor Probe.
Johan SK; Lobo D; Athiyamaan MS; Srinivas C; Banerjee S; Abhishek K; Saxena PUP
Asian Pac J Cancer Prev; 2023 Mar; 24(3):897-907. PubMed ID: 36974543
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered.
Allahverdi M; Sarkhosh M; Aghili M; Jaberi R; Adelnia A; Geraily G
Radiat Prot Dosimetry; 2012 Jul; 150(3):312-5. PubMed ID: 22128355
[TBL] [Abstract][Full Text] [Related]
8. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
Wang Z; Jaggernauth W; Malhotra HK; Podgorsak MB
Med Dosim; 2010; 35(4):269-73. PubMed ID: 19944586
[TBL] [Abstract][Full Text] [Related]
9. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
10. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.
Huh SJ; Lim DH; Ahn YC; Lee JE; Kang MK; Shin SS; Shin KH; Kim B; Park W; Han Y
Strahlenther Onkol; 2003 Mar; 179(3):191-6. PubMed ID: 12627263
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of
Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
[TBL] [Abstract][Full Text] [Related]
14. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of vaginal vault ovoid brachytherapy versus intensity-modulated radiation therapy plans in postoperative patients of cervical carcinoma following whole pelvic radiotherapy.
Khosla D; Patel FD; Oinam AS; Tomar P; Sharma SC
J Cancer Res Ther; 2014; 10(1):153-8. PubMed ID: 24762503
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy.
Shukla AK; Rana BS; Singh NP; Kumar S
Brachytherapy; 2019; 18(2):180-185. PubMed ID: 30616914
[TBL] [Abstract][Full Text] [Related]
17. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
18. A treatment planning study comparing HDR and AGIMRT for cervical cancer.
Wahab SH; Malyapa RS; Mutic S; Grigsby PW; Deasy JO; Miller TR; Zoberi I; Low DA
Med Phys; 2004 Apr; 31(4):734-43. PubMed ID: 15124990
[TBL] [Abstract][Full Text] [Related]
19. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
20. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]